MDPI and ACS Style
Thomssen, C.; Vetter, M.; Kantelhardt, E.J.; Meisner, C.; Schmidt, M.; Martin, P.M.; Clatot, F.; Augustin, D.; Hanf, V.; Paepke, D.;
et al. Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group. Cancers 2023, 15, 1580.
https://doi.org/10.3390/cancers15051580
AMA Style
Thomssen C, Vetter M, Kantelhardt EJ, Meisner C, Schmidt M, Martin PM, Clatot F, Augustin D, Hanf V, Paepke D,
et al. Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group. Cancers. 2023; 15(5):1580.
https://doi.org/10.3390/cancers15051580
Chicago/Turabian Style
Thomssen, Christoph, Martina Vetter, Eva J. Kantelhardt, Christoph Meisner, Marcus Schmidt, Pierre M. Martin, Florian Clatot, Doris Augustin, Volker Hanf, Daniela Paepke,
and et al. 2023. "Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group" Cancers 15, no. 5: 1580.
https://doi.org/10.3390/cancers15051580